EICHOR
● Recruiting
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
Condition: Pulmonary Arterial Hypertension · Sponsor: Gossamer Bio USA, Inc.
About this study
This open-label extension study will evaluate the long-term safety, tolerability and efficacy of orally inhaled seralutinib in subjects who have completed a previous seralutinib study
This description comes directly from the study's public registry record.
Talk to the study team
GB002 Inc. · 1-866-668-4083 · ClinicalTrials@gossamerbio.com
Always discuss trial participation with your own doctor first.
Locations (120)
| Valley Advanced Lung Diseases Institute | Fresno, California, United States | Recruiting |
| Department of Veterans Affairs Greater Los Angeles Healthcare System | Los Angeles, California, United States | Recruiting |
| UC Davis Health Medical Center | Sacramento, California, United States | Recruiting |
| Stanford Healthcare | Stanford, California, United States | Recruiting |
| University of Florida Health | Gainesville, Florida, United States | Recruiting |
| Mayo Clinic Jacksonville | Jacksonville, Florida, United States | Recruiting |
| Piedmont Physicians Pulmonary & Sleep Medicine of Buckhead | Atlanta, Georgia, United States | Recruiting |
| The Emory Clinic | Atlanta, Georgia, United States | Recruiting |
| Northside Hospital - Atlanta | Atlanta, Georgia, United States | Recruiting |
| UI Health Hospital | Chicago, Illinois, United States | Recruiting |
| University of Kansas Medical Center | Kansas City, Kansas, United States | Recruiting |
| Norton Pulmonary Specialists | Louisville, Kentucky, United States | Recruiting |
+ 108 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06274801